Any assistance or transportation required to get medications into the home should not be taken into consideration when answering OASIS items M2020 and M2030, CMS clarified in the quarterly Q&As, released April 19.
Use occupational therapists more often to evaluate patients’ environments, and you’ll reduce the number of visits that need to be completed and improve the patients’ outcomes.
When OASIS-E goes into effect on Jan. 1, 2023, agencies will be required to report when and how medication reconciliation occurs when the patient leaves the agency.
Recent CMS guidance on how to answer M2020 (Management of oral medications) and M2030 (Management of injectable medications) represents a shift from previous guidance.
Check out this OASIS Q&A with answers provided by Karen Tibbs, RN, MS, HCS-D, COS-C, quality manager OASIS and coding with McBee Associates.
Agencies should start educating staff now and not wait until the last minute to prepare for the upcoming implementation of OASIS-E on Jan. 1, 2023.
Use these scenarios related to GG0130A (Eating) to quiz your clinicians and ensure accuracy and compliance.
Following a two-year delay in implementation due to the COVID-19 public health emergency (PHE), OASIS-E will be required for assessments beginning Jan. 1, 2023.
To really move the needle on 5-star ratings, leaders should meet with clinicians who are conducting OASIS assessments at key points including start of care, resumption of care, discharge or transfer.
Whether to transfer a patient with a discharge or without discharge has been causing much confusion among agencies in wake of the Patient-Driven Groupings Model (PDGM) implementation on Jan. 1.


User Name: